跳至主要内容
临床试验/CTRI/2025/03/081840
CTRI/2025/03/081840尚未招募3 期

Intravitreal triamcinolone acetonide injection for the treatment of cystoid macular edema in patients presenting to tertiary eye care center of central india:A prospective study

Shweta sanjiv chopade1 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2025年3月20日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
37
试验地点
1
主要终点
central macular thickness and visual acuity.

研究概览

简要总结

study of effect and complications of use of intravitreal triamcinolone acetonide injection for treatment of cystoid macular edema in non affording population at tertiary eye care centre central india. triamcinolone acetonide being affordable steroid compared with anti VEGF agents use for its anti-inflammatory action to reduce macular edema in patients with macular edema. Its use to improve visual acuity by reducing edema and complications associated with it are being studied in this study.

研究设计

研究类型
Interventional
分配方式
Other
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with cystoid macular edema.
  • patients willing to participate.

排除标准

  • Patients with history of glaucoma.
  • history of eye injury.

结局指标

主要结局

central macular thickness and visual acuity.

时间窗: 4 weeks ,3months,6months

次要结局

  • improvement in best corrected visual acuity.(at day 1,15th day,4weeks & 3months,6months)

研究者

发起方
Shweta sanjiv chopade
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr.Shweta sanjiv chopade

Government medical college,Nagpur.

研究点 (1)

Loading locations...

相似试验